Mannkind (MNKD) Non-Current Assets (2010 - 2026)
Mannkind (MNKD) reported Non-Current Assets of $493.2 million for Q1 2026, up 261.6% year-over-year from $136.4 million in Q1 2025, and down 1.47% on a QoQ basis from $500.6 million in Q4 2025.
Mannkind (MNKD) has 17 years of Non-Current Assets data on file, last reported at $493.2 million in Q1 2026.
- Quarterly Non-Current Assets rose 261.6% year-over-year to $493.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 144.46% YoY) and the FY2025 annual result came in at $500.6 million, up 298.77% from the prior year.
- Non-Current Assets fell to $493.2 million in Q1 2026 per MNKD's latest filing, from $500.6 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $500.6 million in Q4 2025 and bottomed at $60.4 million in Q4 2022.
- The 5-year median for Non-Current Assets is $117.9 million (2024), against an average of $152.0 million.
- Peak annual rise in Non-Current Assets reached 299.66% in 2022, while the deepest fall reached 40.61% in 2022.
- Tracing MNKD's Non-Current Assets over 5 years: stood at $60.4 million in 2022, then jumped by 68.59% to $101.8 million in 2023, then climbed by 23.31% to $125.5 million in 2024, then jumped by 298.77% to $500.6 million in 2025, then retreated by 1.47% to $493.2 million in 2026.
- Per Business Quant, the three latest MNKD Non-Current Assets figures stand at $493.2 million (Q1 2026), $500.6 million (Q4 2025), and $135.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 22.66 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 910.24 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 493.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 493.24 Mn |
| Dec 31, 2025 | 500.60 Mn |
| Sep 30, 2025 | 135.80 Mn |
| Jun 30, 2025 | 132.67 Mn |
| Mar 31, 2025 | 136.40 Mn |
| Dec 31, 2024 | 125.54 Mn |
| Sep 30, 2024 | 136.54 Mn |
| Jun 30, 2024 | 117.90 Mn |
| Mar 31, 2024 | 97.78 Mn |
| Dec 31, 2023 | 101.81 Mn |
| Sep 30, 2023 | 94.75 Mn |
| Jun 30, 2023 | 83.19 Mn |
| Mar 31, 2023 | 74.84 Mn |
| Dec 31, 2022 | 60.39 Mn |
| Sep 30, 2022 | 75.46 Mn |
| Jun 30, 2022 | 92.32 Mn |
| Mar 31, 2022 | 124.05 Mn |
| Dec 31, 2021 | 101.67 Mn |
| Sep 30, 2021 | 79.00 Mn |
| Jun 30, 2021 | 72.89 Mn |
| Mar 31, 2021 | 31.04 Mn |
| Dec 31, 2020 | 29.13 Mn |
| Sep 30, 2020 | 29.34 Mn |
| Jun 30, 2020 | 30.20 Mn |
| Mar 31, 2020 | 30.86 Mn |
| Dec 31, 2019 | 32.97 Mn |
| Sep 30, 2019 | 33.40 Mn |
| Jun 30, 2019 | 31.96 Mn |
| Mar 31, 2019 | 31.27 Mn |
| Dec 31, 2018 | 25.85 Mn |
| Sep 30, 2018 | 25.83 Mn |
| Jun 30, 2018 | 26.36 Mn |
| Mar 31, 2018 | 26.85 Mn |
| Dec 31, 2017 | 27.36 Mn |
| Sep 30, 2017 | 27.85 Mn |
| Jun 30, 2017 | 28.44 Mn |
| Mar 31, 2017 | 29.09 Mn |
| Dec 31, 2016 | 29.58 Mn |
| Sep 30, 2016 | 47.53 Mn |
| Jun 30, 2016 | 48.67 Mn |
| Mar 31, 2016 | 49.13 Mn |
| Dec 31, 2015 | 49.76 Mn |
| Sep 30, 2015 | 206.78 Mn |
| Jun 30, 2015 | 206.72 Mn |
| Mar 31, 2015 | 201.73 Mn |
| Dec 31, 2014 | 193.29 Mn |
| Sep 30, 2014 | 193.30 Mn |
| Jun 30, 2014 | 191.40 Mn |
| Mar 31, 2014 | 185.15 Mn |
| Dec 31, 2013 | 182.37 Mn |
| Sep 30, 2013 | 188.28 Mn |
| Jun 30, 2013 | 180.27 Mn |
| Mar 31, 2013 | 182.91 Mn |
| Dec 31, 2012 | 184.50 Mn |
| Sep 30, 2012 | 187.13 Mn |
| Jun 30, 2012 | 190.05 Mn |
| Mar 31, 2012 | 191.71 Mn |
| Dec 31, 2011 | 193.73 Mn |
| Sep 30, 2011 | 196.99 Mn |
| Jun 30, 2011 | 201.50 Mn |
| Dec 31, 2010 | 203.30 Mn |